Biotech in China : Innovation, Politics, and Economics book cover
1st Edition

Biotech in China
Innovation, Politics, and Economics

  • Available for pre-order. Item will ship after July 16, 2021
ISBN 9789814877534
July 16, 2021 Forthcoming by Jenny Stanford Publishing
344 Pages 38 Color & 54 B/W Illustrations

SAVE ~ $29.99
was $149.95
USD $119.96

Prices & shipping based on shipping country


Book Description

In her quest for a global leadership in science and technology, the People’s Republic of China has attained top ranks in the number of scientific publications, “hot papers,” or national and international patent applications. This also pertains to fields such as biomedicine, agricultural and industrial biotechnology, as well as environmental monitoring and sanitation. However, analysis of the underlying structures and mechanisms is hindered by the sheer flood of data, by stringent government control of all media, including the internet; and by ambiguities inherent in translation from Chinese.

This book tries to overcome these difficulties and provides a concise picture of the biotechnology-related research and development (R&D) in China.

The book begins with brief accounts of China’s geography, people, and their mindset; her political and administrational structure, economy, and finance; her infrastructure related to science and technology; and her educational system and R&D landscape. It then presents succinct accounts on structures and developments in biomedicine, diagnostics, agriculture, fermented food, bioindustry, and environmental biotechnology, with reference to government, industry, and academia. It finally attempts to predict next steps in Chinese biotechnology, both for the national agenda and in view of China’s ambitious global development strategy, the Belt and Road Initiative.

Table of Contents

Biotechnology in China

View More



Rolf Schmid is honorary professor at Nanjing Tech University, China, and founder of Bio4Business, Germany. He studied biochemistry at the Ludwig Maximilian University of Munich and the Albert Ludwig University of Freiburg, Germany, and obtained his MBA from the University of Reutlingen, Germany. For 35 years, Prof. Dr. Schmid has led teams on biotechnology research and development in various German industries and at the Technical University of Braunschweig and the University of Stuttgart, Germany. He has 380 publications, 5 books, and about 80 patents or patent applications to his credit.

Xin Xiong is a group leader for biofunctionalized surfaces at the Natural and Medical Sciences Institute (NMI) in Reutlingen, Germany. He earned his PhD from the University of Stuttgart, after which he worked as a scientist at the Institute of Technical Biochemistry (Group Biocatalysis), University of Stuttgart; Institute for Experimental Internal Medicine, University Hospital Magdeburg, Germany; and the Biomaterials Group at the NMI. His research focuses on biomaterials for medical and biotechnological approaches, in particular, collagen-based biomaterials for regenerative medicine and enzyme immobilization.